Drug Profile
Research programme: thiazolide antiviral therapeutics - Romark Laboratories
Alternative Names: Aminoxanide - Romark Laboratories; L-tert-leucyl thiazolide - Romark Laboratories; RM-4864; RM-4865; RM-5038; RM-5061; RM-5064; RM-6427Latest Information Update: 28 May 2023
Price :
$50
*
At a glance
- Originator Romark Laboratories
- Developer Romark Laboratories; Stanford University
- Class Small molecules; Thiazoles
- Mechanism of Action EIF-2 kinase modulators; HN protein inhibitors; Oxidoreductase inhibitors; Receptor protein-tyrosine kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cryptosporidiosis; Hepatitis B; Viral infections
- Discontinued Hepatitis C; Hepatitis D; Herpes simplex virus infections; Respiratory syncytial virus infections
Most Recent Events
- 28 May 2023 No recent reports of development identified for research development in Cryptosporidiosis in France (Parenteral)
- 28 May 2023 No recent reports of development identified for research development in Cryptosporidiosis in United Kingdom (Parenteral)
- 28 May 2023 No recent reports of development identified for research development in Cryptosporidiosis in USA (Parenteral)